You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news.
2021 has seen tremendous appreciation in cannabis stocks, but the past eleven trading sessions have left prices well below the peak on February 10th. The New Cannabis Ventures Global Cannabis Stock Index is up 50% in just the past 8 weeks, and this follows a 62% advance in Q4, but the index has declined almost 28% since February 10th:
The strength since the end of the year can be attributed to the Democrats taking control of the Senate in early January following two runoff elections in Georgia. Investors have become excited by the prospects for federal legalization. Despite a substantial amount of equity offerings, strong investor demand, which includes institutions taking down some of these new issues, has helped the stocks to maintain most of their gains.
In our view, the market got a bit ahead of itself (we warned our subscribers at 420 Investor at the end of the first week in February), but this recent pullback sets the stage for a potential advance in the coming weeks, especially for American operators, as they are poised to benefit from what we expect will be a very solid earnings season that kicks off when Curaleaf reports on March 9th. For a look at all of the currently scheduled releases, please consult the New Cannabis Ventures earnings calendar.
We expect Q4 was yet another quarter of solid financial performance for the largest MSOs, with strong revenue growth and improving profitability, and investors are likely to be pleased. Taking a look at the leading MSOs by market cap and/or revenue using Sentieo as our data source, the typical MSO is expected to report year-over-year revenue growth of 112%.
Of the 11 companies, six are expected to show acceleration from the prior quarter. Of the five that are expected to slow, all but one are still more than doubling revenue from a year ago. These numbers are likely to excite investors in our view.
Like last quarter, we are hopeful that more companies will provide guidance for 2021. That wasn’t the case in November, with still only Jushi Holdings and TerrAscend guiding at this time. In an interview with New Cannabis Ventures in December, Curaleaf CEO Joseph Bayern stated that the company would provide 2021 guidance when it releases Q4 financials. Given that the company’s guidance is very likely to be in excess of $1 billion revenue (consensus is $1.26 billion), this could be a catalyst for the entire sector, as the media is likely to pick up on this potential milestone.
Cannabis stocks have performed quite well in 2021 thus far, but this has been due primarily to political developments. We see Q4 earnings reports as a catalyst especially for MSOs, as investors are likely once again to be reminded of how robust industry growth is currently.
For in-depth insights and analysis into the publicly-traded cannabis industry, there is no better source than Alan Brochstein’s 420 Investor premium service. Join the only due diligence platform trusted by cannabis investors for more than 7 years.
New Cannabis Ventures publishes curated articles as well as exclusive news. Here is some of the most interesting business content from this week:
- Acreage Holdings to Sell Florida Cannabis Operations to Red White & Bloom for $60 Million
- Exclusive: Cannabis Companies Kick Off Earnings Season with Strong Reports
- Cronos Group Q4 Revenue Increases 133% to $17 Million with Adjusted EBITDA Loss of $53 million
- Exclusive: Gold Flora Steps on the Gas as California Cannabis Market Accelerates
- GTI Raises Another $56 Million Selling Shares at $35.50
- Indus Holdings Buys Lowell Herb Co. for $39 Million
- Innovative Industrial Properties Q4 Revenue Increases 110% to $37.1 Million
- KushCo Holdings Raises $40 Million Selling Units at $1.65
- MedMen Sells 87% of New York Operations for $73 Million
- Rubicon Organics Closes Upsized $23 Million Capital Raise
- Exclusive: This MSO Is Leveraging Vertical Integration in Its Four Cannabis Markets and Pursuing Acquisitions
- Exclusive: Unnamed Company Tried to Buy Aphria While It Was Negotiating Tilray Merger
- Verano Holdings Raises C$100 Million at C$28.50 in Private Placement
- Wrigley-Led Cannabis MSO Parallel to Go Public Via SPAC Valued at $1.9 Billion
To get real-time updates download our free mobile app for Android or Apple devices, like our Facebook page, or follow Alan on Twitter. Share and discover industry news with like-minded people on the largest cannabis investor and entrepreneur group on LinkedIn.
Get ahead of the crowd! If you are a cannabis investor and find value in our Sunday newsletters, subscribe to 420 Investor, Alan’s comprehensive stock due diligence platform since 2013. Gain immediate access to real-time and in-depth information and market intelligence about the publicly traded cannabis sector, including daily videos, weekly chats, model portfolios, a community forum and much more.
Use the suite of professionally managed NCV Cannabis Stock Indices to monitor the performance of publicly-traded cannabis companies within the day or over longer time-frames. In addition to the comprehensive Global Cannabis Stock Index, we offer a family of indices to track Canadian licensed producers as well as the American Cannabis Operator Index.
View the Public Cannabis Company Revenue & Income Tracker, which ranks the top revenue producing cannabis stocks that generate industry sales of more than US$12.5M per quarter.
Stay on top of some of the most important communications from public companies by viewing upcoming cannabis investor earnings conference calls.
Discover upcoming new listings with the curated Cannabis Stock IPOs and New Issues Tracker.
Alan & Joel